Exosome Diagnostics has raised $5 million out of a targeted $6 million offering, GenomeWeb reports. The company will likely use the funding, secured from two investors, to advance development of its molecular diagnostics test for cancer and other diseases. Exosome is also focused on the companion diagnostic space. Story (subs. req.)